doi: 10.1161/hs0302.104112
(Stroke. 2002;33:844.)
© 2002 American Heart Association, Inc.
Original Contributions |
Role of Endothelial Nitric Oxide and Smooth Muscle Potassium Channels in Cerebral Arteriolar Dilation in Response to Acidosis
From the Department of Neurosurgery, Washington University School of Medicine, St Louis, Mo (T.H., H.H.D., R.G.D.), and Department of Neurosurgery, Shinshu University School of Medicine, Matsumoto, Japan (K.H., T.G.).
Correspondence to Hans H. Dietrich, PhD, Department of Neurosurgery, Washington University School of Medicine, Box 8057, 660 S Euclid Ave, St Louis, MO 63110. E-mail DietrichH{at}nsurg.wustl.edu
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Background and Purpose— Potassium channels or nitric oxide or both are major mediators of acidosis-induced dilation in the cerebral circulation. However, these contributions depend on a variety of factors such as species and vessel location. The present study was designed to clarify whether potassium channels and endothelial nitric oxide are involved in acidosis-induced dilation of isolated rat cerebral arterioles.
Methods— Cerebral arterioles were cannulated and monitored with an inverted microscope. Acidosis (pH 6.8 to 7.4) produced by adding hydrogen ions mediated dilation of the cerebral arterioles in a concentration-dependent manner. The role of nitric oxide and potassium channels in response to acidosis was examined with several specific inhibitors and endothelial damage.
Results— The dilation was significantly inhibited by potassium chloride (30 mmol/L) and glibenclamide (3 µmol/L; ATP-sensitive potassium channel inhibitor). We found that 30 µmol/L BaCl2 (concentration-dependent potassium channel inhibitor) also affected the dilation; however, an additional treatment of 3 µmol/L glibenclamide did not produce further inhibition. Tetraethylammonium ion (1 mmol/L; calcium-activated potassium channel inhibitor) and 4-aminopyridine (100 µmol/L; voltage-dependent potassium channel inhibitor) as well as ouabain (10 µmol/L; Na-K ATPase inhibitor) and N-methylsulphonyl-6-(2-proparglyloxyphenyl) hexanamide (1 µmol/L; cytochrome P450 epoxygenase inhibitor) did not alter acidotic dilation. N
-Monomethyl-L-arginine (10 µmol/L) and N-nitro-L-arginine (10 µmol/L) as nitric oxide synthase inhibitor blunted the dilation. Furthermore, the dilation was significantly attenuated after the endothelial impairment. Additional treatment with glibenclamide (3 µmol/L) further reduced the dilation in response to acidosis.
Conclusions— Endothelial nitric oxide and smooth muscle ATP-sensitive potassium channels contribute to acidosis-induced dilation of rat cerebral arterioles. Endothelial damage caused by pathological conditions such as subarachnoid hemorrhage or traumatic brain injury may contribute to reduced blood flow despite injury-induced cerebral acidosis.
Key Words: acid-base equilibrium • cerebral circulation • hydrogen-ion concentration • microcirculation • rats
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
It is well known that hypercapnic and normocapnic acidosis cause vasodilation in cerebral blood vessels.1–4 Decrease in the extracellular pH plays an important role in acidosis-induced dilation.5,6 As such, the hydrogen-ion concentration is one of the regulators of this response in the cerebral microcirculation.3,4
In the cerebral circulation, neuronal and/or endothelial nitric oxide (NO) is known as the regulator of acidosis-induced dilation.7–10 Recently, Lindauer et al11 found that in isolated rat middle cerebral artery, denudation did not alter the vessel response to acidosis, favoring neuronal but not endothelial NO as a modulator of pH-dependent vasoreactivity in this preparation. In addition, ATP-sensitive potassium (KATP) channels in vascular smooth muscle have received attention as major contributors to acidosis-induced dilation in pial vessels and basilar artery.7,9
While there are numerous reports studying pH-dependent vasomotor mechanisms in cerebral arteries and pial vessels,1,2,5,7 only few studies concerning such mechanisms in cerebral arterioles exist. These arterioles are in close contact with the supplied tissue and are strong regulators of cerebrovascular tone, representing approximately 23% of the total arterial cerebrovascular resistance.12 Previously, our laboratory reported that rat isolated cerebral arterioles were very sensitive to the extracellular acidosis, produced by adding hydrogen ions, that caused dilation and hyperpolarization of vascular smooth muscle cell.3,4,13 Furthermore, we also speculated that endothelial NO may be involved in part in acidosis-mediated dilation.13 However, the contribution of the endothelium or potassium channels to acidic vasodilation in these microvessels is not known. With the use of specific inhibitors for various potassium channel types, NO synthase (NOS), cyclooxygenase, cytochrome P450 epoxygenase, Na-K ATPase, and endothelial damage, the present study was designed to determine the mechanisms and cell type involved in acidosis-induced dilation in isolated rat cerebral arterioles. Implications of our findings on the physiology and pathophysiology of cerebrovascular regulation are discussed.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Animal Preparation
All animal experimentation was approved by the Institutional Animal Care and Use Committee. Sprague-Dawley rats (weight, 450±8 g; n=48; Harlan, Indianapolis, Ind) were anesthetized with injection of pentobarbital sodium (65 mg/kg IP) and killed. The brain was carefully removed and placed in a cold (4°C) dissection chamber filled with 3-(N-morpholino)propanesulfonic acid (MOPS)-buffered saline (see below for composition) containing 1% dialyzed bovine serum albumin.
Isolation and Cannulation of Arterioles
The technique for isolation of cerebral penetrating arteriole was previously described in detail.3 Briefly, unbranched penetrating arterioles were obtained from the middle cerebral artery and transferred to an organ bath. The arteriole was cannulated at one end and occluded at the other end with micropipettes. The internal diameter of arteriole was continuously monitored under an inverted microscope (Diaphot, Nikon) coupled to a charge-coupled device camera (Dage-MTI). Each arteriole was equilibrated with room air. The organ bath was heated from room temperature to 37.5°C and perfused with a peristaltic pump at a rate of 0.5 mL/min. Within 30 minutes, the arteriole developed spontaneous tone with a pH of 7.4.5 We discarded vessels with poor tone (<20% decrease from the maximum diameter) for further studies.
Chemicals
MOPS-buffered saline was used with the following composition (in mmol/L): NaCl 144, KCl 3.0, CaCl2 2.5, MgSO4 1.4, pyruvate 2.0, glucose 5.0, EDTA 0.02, NaH2PO4 1.21, and MOPS 2.0. The following drugs were purchased: tetraethylammonium ion (TEA), glibenclamide, 4-aminopyridine (4-AP), KCl, BaCl2, N-monomethyl-L-arginine (L-NMMA), N-nitro-L-arginine (L-NNA), ouabain, and indomethacin (Sigma). N-Methylsulfonyl-6-(2-proparglyloxyphenyl) hexanamide (MS-PPOH) was a gift from Dr John R. Falck (Department of Biochemistry and Pharmacology, University of Texas Southwestern Medical Center).
Experimental Protocols
Acidosis-induced dilation was studied by adding HCl (0.1N) to MOPS-buffered saline to reduce extravascular pH. The internal diameter was measured at pH 7.4 (as control), 7.2, 7.0, and 6.8 before and after endothelial impairment and/or administration of several inhibitors. Previously, we confirmed that acidosis-induced dilations were reproducible.14
The high-K+ saline (30 mmol/L) was used to negate any effects of K+ channels.15 Isotonic high-K+ MOPS-buffered saline was prepared by substituting NaCl with an equimolar amount of KCl.
To confirm what type of K+ channels is involved in acidosis-induced dilation, we used 4 K+ channel inhibitors16–18: 3 µmol/L glibenclamide specific for KATP channels, 1 mmol/L TEA specific for calcium-activated K+ (KCa) channels, 100 µmol/L 4-AP to inhibit voltage-dependent K+ (KV) channels, and 30 µmol/L BaCl2 specific for inward rectifier K+ (KIR) channels. BaCl2 is a dose-dependent potassium channel inhibitor,9,16 and we used concentrations established previously.17,18
Either 10 µmol/L L-NMMA (NOS inhibitor) or 10 µmol/L indomethacin (a cyclooxygenase inhibitor) was administered extraluminally to test whether NO or prostaglandins contribute to the acidosis-induced dilation, respectively.19,20
The effects of functional disruption of endothelium on the acidosis-induced responses were investigated. After a control dilation in response to acidosis was obtained, the endothelium was impaired by passing air through the lumen of the arteriole at 60 mm Hg. This method has been previously reported in detail.14 To ensure the function of the arteriolar smooth muscle, we obtained a dose-dependent dilation of the arterioles in response to sodium nitroprusside (SNP) (0.1 nmol/L to 10 µmol/L) before and after air emboli. Extraluminal application of acetylcholine does not produce dilation of this preparation21; we therefore confirmed endothelial but not smooth muscle cell damage with extraluminal propidium iodide (5 µmol/L) after air embolism.14 After air embolization, we previously reported that L-NMMA did not cause constriction of our preparation.22 This result indicated that endothelial but not neuronal NO played an important role in regulation of our preparations.
We also examined the effect of MS-PPOH (1 µmol/L) and ouabain (10 µmol/L). MS-PPOH and ouabain were used as inhibitors of cytochrome P450 epoxygenase23,24 and Na-K ATPase, respectively.
In a separate series of experiments, we studied the effect of 10 µmol/L L-NNA (NOS inhibitor) with or without 3 µmol/L glibenclamide on acidosis-induced dilation.
Each antagonist was incubated for at least 20 minutes.
Statistical Analysis
Only 1 vessel was studied from 1 rat brain. All data are presented as mean±SEM. The n denotes the number of the vessels used in this study. For concentration-response curves, the results are presented as percentage of the maximum diameter of the arteriole and calculated by the following equation: % maximum diameter=[(Dacidosis-Dbase)/(Dmax-Dbase)]x100, where Dmax, Dbase, and Dacidosis are the maximum diameter of the vessel at 60 mm Hg, the control diameter of the vessel before introducing acidosis, and the diameter of the vessel after dilation, respectively. Dmax is the diameter after application of transmural pressure of 60 mm Hg at room temperature and before development of the spontaneous tone, which is comparable to maximal dilation induced by papaverine.13 Significant differences (P<0.05) were determined by repeated-measures ANOVA with a post hoc Student-Newman-Keuls test and paired Student’s t test, as appropriate.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
The passive maximum arteriolar diameter (the maximum diameter) was 64.7±1.6 µm (n=48). All vessels developed spontaneous tone, constricting to an average diameter of 45.7±1.4 µm (-29.4±1.2% of the maximum diameter).
Effect of High Potassium and Potassium Channel Inhibitors
Extraluminal application of 30 mmol/L KCl significantly decreased the arteriolar diameter (Table 1). High-K+ solution significantly attenuated but did not abolish the dilation in response to acidosis (n=5; Figure 1). BaCl2 (30 µmol/L) and 4-AP (100 µmol/L) constricted the vessel (Table 1), while neither TEA (1 mmol/L) nor glibenclamide (3 µmol/L) affected the control diameter (Table 1). The acidosis-induced dilation was inhibited by either 3 µmol/L glibenclamide (n=5; Figure 2) or 30 µmol/L BaCl2 (n=4; Figure 3). Treatment with 3 µmol/L glibenclamide in addition to 30 µmol/L BaCl2 did not produce further reduction of dilation (n=4; Figure 3). In contrast, neither 1 mmol/L TEA (n=4; Table 2) nor 100 µmol/L 4-AP (n=4; Table 2) altered the dilation.
|
|
|
|
|
Effect of L-NMMA and Indomethacin
Indomethacin (10 µmol/L) did not affect the control diameter and the dilation in response to acidosis (n=4; Table 2). Extraluminally applied L-NMMA (10 µmol/L) caused a significant constriction (Table 1) and attenuated the acidosis-evoked dilation (n=5; Figure 4).
|
Effect of Endothelial Impairment
The air emboli significantly constricted the vessel (Table 1). Functional endothelial impairment blunted the dilation in response to acidosis (n=5; Figure 5). Administration of glibenclamide (3 µmol/L) after air emboli induced further inhibition of the dilation (n=5; Figure 5). SNP-induced dilations of cerebral arterioles were not different before and after air embolus (n=5, Figure 6). This result shows that smooth muscle viability did not change before and after air emboli.
|
significant differences (P<0.05) from endothelial impairment.
|
Effect of MS-PPOH and Ouabain
MS-PPOH (n=4) and ouabain (n=3) contributed to neither the control diameter nor acidosis-induced dilation (Table 2). Ouabain itself constricted the vessel transiently, but the vessel diameter returned to control within 15 minutes.
Effect of L-NNA With Glibenclamide
L-NNA (10 µmol/L) constricted the vessels (Table 1) and inhibited the dilation in response to acidosis (n=5; Table 3). Additional treatment with glibenclamide (3 µmol/L) produced further impairment of dilation without change of basal diameter (n=5; Table 3).
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
The results of the present study indicate the following: (1) The dilation in response to acidosis is attenuated by glibenclamide, BaCl2, and L-NMMA but not by TEA, 4-AP, indomethacin, MS-PPOH, and ouabain. (2) Endothelial impairment and L-NNA attenuated the dilation in response to acidosis, which was further decreased by glibenclamide. We conclude that in cerebral arterioles, dilation in response to acidosis is regulated by endothelial NO and smooth muscle KATP channel.
Hypercapnic and Normocapnic Acidosis
Previous studies indicate that there are differences in the mechanisms of hypercapnic and normocapnic acidosis between vascular beds.1,2 However, both lead to an increase in hydrogen ions, and the direct and/or indirect effects of them are related to acidosis-induced dilation via both potassium and calcium channels in vascular smooth muscle.2
Role of Potassium Channels in Dilation in Response to Acidosis
Potassium ion (30 mmol/L) can inhibit the activity of all potassium channels.9,15 In this study the acidosis-induced dilation is significantly attenuated but not abolished by extracellular K+ ion. This result suggests that there are at least 2 mechanisms for the dilation in response to acidosis: K+ channel-dependent and -independent mechanisms.
It is known that smooth muscle KATP channels are important mediators of the dilation in response to acidosis in cerebral arteries9 as well as pial arterioles.7 These findings are consistent with our study because glibenclamide (3 µmol/L) diminished the dilation in response to acidosis before and after endothelial impairment. We17 and others18 confirmed that up to 3 µmol/L glibenclamide was sufficient and specific for KATP channels because this concentration abolished the KATP channel opener-induced dilation. In addition, we previously reported that acidosis caused hyperpolarization of smooth muscle cells in rat cerebral arterioles.4 Thus, acidosis can hyperpolarize the smooth muscle cell, resulting in dilation via activation of smooth muscle KATP channels in rat cerebral arterioles. However, we cannot exclude the possibility that endothelial KATP channels also contribute to acidosis-induced dilation.
Recently, Suzuki and colleagues25 demonstrated that a pH-sensitive K+ channel is present in the rabbit cerebral arterial smooth muscle. It is characterized by an inward rectifier current and blocked by Ba2+. BaCl2 is a concentration-dependent K+ channel inhibitor,9,18 and a low concentration of BaCl2 (<50 µmol/L) has been shown to be a selective antagonist of KIR channels26 that does not inhibit KATP channels in rat basilar artery.27,28 In the present study BaCl2 (30 µmol/L) also attenuated the dilation in response to acidosis, which was similar in degree to the reduction induced by glibenclamide. However, additional treatment with glibenclamide did not produce a further reduction of dilation. These results indicate that 30 µmol/L BaCl2 may inhibit KIR as well as KATP channels in rat cerebral arterioles. However, we cannot exclude the contribution of KIR channels to acidosis-induced dilation. Nguyen et al18 recently have shown that both KATP and KIR channels are blocked by 30 µmol/L BaCl2 in rat cerebral arterioles, similar to our preparation. Thus, there may be a difference in the action of BaCl2 as an inhibitor of potassium channels along the rat arterial tree. Since the action of glibenclamide as an inhibitor of KATP channels was consistent for both macrovessels and microvessels,18,27 we speculate that activation of KATP channels may be essential to acidosis-induced dilation rather than KIR channels.
KCa and KV channels in rat cerebral arterioles appear to be ruled out as mediators of dilation because TEA and 4-AP did not affect the dilation in response to acidosis. On the other hand, the KV channel is involved in reduction of the extracellular pH in cat cerebral arterial smooth muscle cells.29 Wang et al30 have demonstrated that, in rat pial arterioles in vivo, KCa channel inhibitor did not block the dilatory response to acidosis under basal conditions, whereas KCa channels can be activated by acidosis in the presence of neuronal NOS inhibition. These studies strongly suggest that several types of potassium channels may participate in acidosis-mediated cerebral dilatory responses depending on a variety of factors, such as species or organ studied.
Role of NO in Dilation in Response to Acidosis
The finding that L-NMMA, L-NNA, and endothelial impairment reduced the acidosis-induced dilation, but indomethacin did not, indicates that endothelial NO is involved. We previously demonstrated that L-NMMA (10 µmol/L) and L-NNA (10 µmol/L) were sufficient as the NOS inhibitor.19,20 On the basis of in vivo studies,7,8,31 NO is an important mediator of cerebral dilation in response to acidosis. Irikura et al32 have suspected that neuronal but not endothelial NOS may be activated by acidosis. In addition, neuronal NO dose not appear to be from the perivascular nerves of the vessels.31 On the other hand, in vitro studies showed acidosis induced endothelium-independent dilation in large cerebral arteries such as dog or monkey middle cerebral or rat basilar arteries,33–35 suggesting that endothelial NO did not alter this response. Recently, Lindauer et al11 confirmed in isolated rat middle cerebral artery that denudation did not alter the response to acidotic dilation. However, the present study in rat cerebral arterioles clearly demonstrated that endothelial NO contributes to acidosis-induced dilation. Thus, there appears to be a regional difference between large cerebral arteries and cerebral arterioles in response to acidosis-mediated dilation.
There are 2 possible explanations for the contribution of endothelial NO to acidic dilation: (1) Acidosis increases the production of NO because NOS may be activated by acidosis.36,37 (2) Acidosis protects spontaneously released NO from its degradation because NO is stable in acidosis.38,39 In the cerebral circulation, it would seem that NO acts as an amplifier but not a mediator for the response to dilation caused by acidosis.39 We previously reported that endothelial NO was basally released and regulated arteriolar tone in rat cerebral arterioles.19 Thus, it is possible that acidosis increases the net action of basal NO, resulting in dilation of arterioles.
Role of Other Mediators
Several substances may be considered to be other mediators of dilation in response to acidosis. Involvement of prostanoids and electrogenic Na+ pump in acidosis-induced cerebral dilation has been postulated in newborn pigs,40 monkeys,34 and dogs.33 However, treatment with indomethacin or ouabain failed to attenuate the acidosis-mediated dilation in isolated rat cerebral arterioles. These observations indicate that prostanoids and electrogenic Na+ pump play little role in the response to acidosis. It is possible that newly synthesized products of cytochrome P450 epoxygenase contribute to the dilation during acidosis because acidosis causes smooth muscle hyperpolarization4 and endothelial impairment attenuates the dilation in response to acidosis in isolated rat cerebral arterioles. Cytochrome P450 metabolites41 are known to be one of the endothelium-derived hyperpolarizing factors. However, MS-PPOH, the cytochrome P450 epoxygenase inhibitor,23,24 had no effect on acidosis-induced dilation in our study.
Physiological and Pathophysiological Consequences
Our data indicate that in cerebral arterioles the endothelium contributes to acidic vasodilation, which differentiates these vessel from large cerebral arteries where the endothelium seems not to contribute to acidic dilation.11 Pathological conditions such as subarachnoid hemorrhage or traumatic brain injury can cause endothelial dysfunction42,43 and cerebral acidosis.44,45 Decreased microvascular dilation due to lack of endothelial pH response may therefore contribute to the cerebral hypoperfusion seen after subarachnoid hemorrhage or traumatic injury despite the acidosis caused by these injuries.
In conclusion, the present study shows that acidosis stimulates smooth muscle KATP channels, resulting in dilation of isolated rat cerebral arterioles, but depends neither on cyclooxygenase or cytochrome P450 products nor on activation of Na-K ATPase. In addition, endothelial NO modulates the dilation caused by acidosis, which differentiates cerebral arteriolar responses from responses of large cerebral arteries.
|
Acknowledgments |
|---|
This study was supported by National Institutes of Health grants HL57540 and NS30555. We are very grateful to Christine M. Pluchinsky for her technical assistance.
Received May 18, 2001; revision received December 5, 2001; accepted December 5, 2001.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
1. Aalkjaer C, Peng HL. pH and smooth muscle. Acta Physiol Scand. 1997; 161: 557–566.[CrossRef][Medline] [Order article via Infotrieve]
2. Aalkjaer C, Poston L. Effects of pH on vascular tension: which are the important mechanisms? J Vasc Res. 1996; 33: 347–359.[Medline] [Order article via Infotrieve]
3. Dacey RG Jr, Duling BR. A study of rat intracerebral arterioles: methods, morphology, and reactivity. Am J Physiol. 1982; 243: H598–H606.
4. Dietrich HH, Dacey RG Jr. Effects of extravascular acidification and extravascular alkalinization on constriction and depolarization in rat cerebral arterioles in vitro. J Neurosurg. 1994; 81: 437–442.[Medline] [Order article via Infotrieve]
5.
Kontos HA, Raper AJ, Patterson JL. Analysis of vasoactivity of local pH, PCO2 and bicarbonate on pial vessels. Stroke. 1977; 8: 358–360.
6.
Tian R, Vogel P, Lassen NA, Mulvany MJ, Andreasen F, Aalkjaer C. Role of extracellular and intracellular acidosis for hypercapnia-induced inhibition of tension of isolated rat cerebral arteries. Circ Res. 1995; 76: 269–275.
7. Faraci FM, Breese KR, Heistad DD. Cerebral vasodilation during hypercapnia: role of glibenclamide-sensitive potassium channels and nitric oxide. Stroke. 1994; 25: 1679–1683.[Abstract]
8.
Iadecola C, Zhang F. Nitric oxide-dependent and -independent components of cerebrovasodilation elicited by hypercapnia. Am J Physiol. 1994; 266: R546–R552.
9.
Kinoshita H, Katusic ZS. Role of potassium channels in relaxations of isolated canine basilar arteries to acidosis. Stroke. 1997; 28: 433–437.
10. Wang Q, Pelligrino DA, Baughman VL, Koenig HM, Albrecht RF. The role of neuronal nitric oxide synthase in regulation of cerebral blood flow in normocapnia and hypercapnia in rats. J Cereb Blood Flow Metab. 1995; 15: 774–778.[Medline] [Order article via Infotrieve]
11.
Lindauer U, Kunz A, Schuh-Hofer S, Vogt J, Dreier JP, Dirnagl U. Nitric oxide from perivascular nerves modulates cerebral arterial pH reactivity. Am J Physiol. 2001; 281: H1353–H1363.
12.
Rosenblum WI, Kontos HA. The importance and relevance of studies of the pial microcirculation. Stroke. 1974; 5: 425–428.
13.
Dietrich HH, Kimura M, Dacey RG Jr. N-Omega-L-arginine constricts cerebral arterioles without increasing intracellular calcium levels. Am J Physiol. 1994; 266: H1681–H1686.
14.
Horiuchi T, Dietrich HH, Tsugane S, Dacey RG. Analysis of purine- and pyrimidine-induced vascular responses in the isolated rat cerebral arteriole. Am J Physiol. 2001; 280: H767–H776.
15. Adeagbo AS, Triggle CR. Varying extracellular [K+]: a functional approach to separating EDHF- and EDNO-related mechanisms in perfused rat mesenteric arterial bed. J Cardiovasc Pharmacol. 1993; 21: 423–429.[Medline] [Order article via Infotrieve]
16.
Faraci FM, Heistad DD. Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev. 1998; 78: 53–97.
17.
Horiuchi T, Dietrich HH, Tsugane S, Dacey RG Jr. Role of potassium channels in regulation of brain arteriolar tone: comparison of cerebrum versus brain stem. Stroke. 2001; 32: 218–224.
18.
Nguyen TS, Winn HR, Janigro D. ATP-sensitive potassium channels may participate in the coupling of neuronal activity and cerebrovascular tone. Am J Physiol. 2000; 278: H878–H885.
19. Kimura M, Dietrich HH, Dacey RG Jr. Nitric oxide regulates cerebral arteriolar tone in rats. Stroke. 1994; 25: 2227–2234.[Abstract]
20. Kajita Y, Takayasu M, Dietrich HH, Dacey RG Jr. Possible role of nitric oxide in autoregulatory response in rat intracerebral arterioles. Neurosurgery. 1998; 42: 834–841.[Medline] [Order article via Infotrieve]
21.
Dacey RG Jr, Bassett JE. Cholinergic vasodilation of intracerebral arterioles in rats. Am J Physiol. 1987; 253: H1253–H1260.
22. Dietrich HH, Dacey RG Jr. Effect of air emboli on conducted vasomotor response in cerebral arterioles. Microcirculation. 1997; 4: 169.Abstract.
23.
Wang MH, Brand-Schieber E, Zand BA, Nguyen X, Falck JR, Balu N, Schwartzman ML. Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors. J Pharmacol Exp Ther. 1998; 284: 966–973.
24.
Bhardwaj A, Northington FJ, Carhuapoma JR, Falck JR, Harder DR, Traystman RJ, Koehler RC. P-450 epoxygenase and NO synthase inhibitors reduce cerebral blood flow response to N-methyl-D-aspartate. Am J Physiol. 2000; 279: H1616–H1624.
25.
Suzuki M, Takigawa T, Kimura K, Koseki C, Imai M. Immunohistochemical localization of pH-sensitive K+ channel, RACTK1. Am J Physiol. 1995; 269: C496–C503.
26.
Johnson TD, Marrelli SP, Steenberg ML, Childres WF, Bryan RM Jr. Inward rectifier potassium channels in the rat middle cerebral artery. Am J Physiol. 1998; 274: R541–R547.
27.
Chrissobolis S, Ziogas J, Chu Y, Faraci FM, Sobey CG. Role of inwardly rectifying K(+) channels in K(+)-induced cerebral vasodilatation in vivo. Am J Physiol. 2000; 279: H2704–H2712.
28.
Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1995; 268: C799–C822.
29. Bonnet P, Rusch NJ, Harder DR. Characterization of an outward K+ current in freshly dispersed cerebral arterial muscle cells. Pflugers Arch Ges Physiol. 1991; 418: 292–296.
30. Wang Q, Bryan RM, Pelligrino DA. Calcium-dependent and ATP-sensitive potassium channels and the "permissive" function of cyclic GMP in hypercapnia-induced pial arteriolar relaxation. Brain Res. 1998; 793: 187–196.[CrossRef][Medline] [Order article via Infotrieve]
31. Iadecola C, Pelligrino DA, Moskowitz MA, Lassen NA. Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab. 1994; 14: 175–192.[Medline] [Order article via Infotrieve]
32.
Irikura K, Huang PL, Ma J, Lee WS, Dalkara T, Fishman MC, Dawson TM, Moskowitz MA. Cerebrovascular alterations in mice lacking neuronal nitric oxide synthase gene expression. Proc Natl Acad Sci U S A. 1995; 92: 6823–6827.
33.
Toda N, Hatano Y, Mori K. Mechanisms underlying response to hypercapnia and bicarbonate of isolated dog cerebral arteries. Am J Physiol. 1989; 257: H141–H146.
34.
Toda N, Ayajiki K, Enokibori M, Okamura T. Monkey cerebral arterial relaxation caused by hypercapnic acidosis and hypertonic bicarbonate. Am J Physiol. 1993; 265: H929–H933.
35. You JP, Wang Q, Zhang W, Jansen-Olesen I, Paulson OB, Lassen NA, Edvinsson L. Hypercapnic vasodilatation in isolated rat basilar arteries is exerted via low pH and does not involve nitric oxide synthase stimulation or cyclic GMP production. Acta Physiol Scand. 1994; 152: 391–397.[Medline] [Order article via Infotrieve]
36. Wang Q, Paulson OB, Lassen NA. Effect of nitric oxide blockade by NG-nitro-L-arginine on cerebral blood flow response to changes in carbon dioxide tension. J Cereb Blood Flow Metab. 1992; 12: 947–953.[Medline] [Order article via Infotrieve]
37. Heinzel B, John M, Klatt P, Bohme E, Mayer B. Ca2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J. 1992; 281: 627–630.
38. Ignarro LJ. Endothelium-derived nitric oxide: actions and properties. FASEB J. 1989; 3: 31–36.[Abstract]
39. Toda N, Ayajiki K, Okamura T. Hypercapnia relaxes cerebral arteries and potentiates neurally-induced relaxation. J Cereb Blood Flow Metab. 1996; 16: 1068–1074.[CrossRef][Medline] [Order article via Infotrieve]
40.
Mirro R, Pharris LJ, Armstead WM, Shibata M, Leffler CW. Effects of indomethacin on newborn pig pial arteriolar responses to PCO2. J Appl Physiol. 1993; 75: 1300–1305.
41. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, Busse R. Cytochrome P4502C is an EDHF synthase in coronary arteries. Nature. 1999; 401: 493–497.[CrossRef][Medline] [Order article via Infotrieve]
42.
Park KW, Metais C, Dai HB, Comunale ME, Sellke FW. Microvascular endothelial dysfunction and its mechanism in a rat model of subarachnoid hemorrhage. Anesth Analg. 2001; 92: 990–996.
43. Alagarsamy S, DeWitt DS, Johnson KM. Effects of moderate, central fluid percussion traumatic brain injury on nitric oxide synthase activity in rats. J Neurotrauma. 1998; 15: 627–633.[Medline] [Order article via Infotrieve]
44. Hoffman WE, Wheeler P, Edelman G, Charbel FT, Torres NJ, Ausman JI. Hypoxic brain tissue following subarachnoid hemorrhage. Anesthesiology. 2000; 92: 442–446.[CrossRef][Medline] [Order article via Infotrieve]
45. Golding EM, Robertson CS, Bryan RM Jr. The consequences of traumatic brain injury on cerebral blood flow and autoregulation: a review. Clin Exp Hypertens. 1999; 21: 299–332.
This article has been cited by other articles:
 |
|
 |
|
  N. Toda, K. Ayajiki, and T. Okamura Cerebral Blood Flow Regulation by Nitric Oxide: Recent Advances Pharmacol. Rev., March 1, 2009; 61(1): 62 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Torring, K. Holmgaard, A. Hessellund, C. Aalkjaer, and T. Bek The Vasodilating Effect of Acetazolamide and Dorzolamide Involves Mechanisms Other Than Carbonic Anhydrase Inhibition Invest. Ophthalmol. Vis. Sci., January 1, 2009; 50(1): 345 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. W. Hein, W. Xu, and L. Kuo Dilation of Retinal Arterioles in Response to Lactate: Role of Nitric Oxide, Guanylyl Cyclase, and ATP-Sensitive Potassium Channels Invest. Ophthalmol. Vis. Sci., February 1, 2006; 47(2): 693 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Y. Kim, G. H. Liang, J. A. Kim, S. H. Park, J. S. Hah, and S. H. Suh Contribution of Na+-K+ pump and KIR currents to extracellular pH-dependent changes of contractility in rat superior mesenteric artery Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H792 - H800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. I. Rosenblum ATP-Sensitive Potassium Channels in the Cerebral Circulation Stroke, June 1, 2003; 34(6): 1547 - 1552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Santa, T. Kitazono, T. Ago, H. Ooboshi, M. Kamouchi, M. Wakisaka, S. Ibayashi, and M. Iida ATP-Sensitive Potassium Channels Mediate Dilatation of Basilar Artery in Response to Intracellular Acidification In Vivo Stroke, May 1, 2003; 34(5): 1276 - 1280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. I. Rosenblum, T. Horiuchi, H. H. Dietrich, K. Hongo, T. Goto, and R. G. Dacey Jr Re: Role of Endothelial Nitric Oxide and Smooth Muscle Potassium Channels in Cerebral Arteriolar Dilation in Response to Acidosis * Response Stroke, July 1, 2002; 33(7): 1742 - 1743. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||